Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Oxurion enrols first patient in Phase l trial of THR-687 for DME

Diabetic macular edema. Credit: National Eye Institute, National Institutes of Health.

Go Top